De-implementing Inhaled Steroids to Improve Care and Safety in COPD
Completed · Not applicable
Conditions studied: Treatment of Chronic Obstructive Pulmonary Disease
In brief
This Quality Enhancement Research Initiative (QuERI) project is designed to determine efficacy and acceptance of an intervention method to provide primary care providers with patient-tailored electronic consults and corresponding unsigned orders for de-implementation of inhaled corticosteroids (ICS) for patients with COPD when ICS are not indicated by guidelines.
Key facts
- Study ID
- NCT02896257
- Run by
- VA Office of Research and Development
- People needed
- 181
- Starts
- 2016-09-06
- Expected to finish
- 2021-06-30
- Last updated by the study team
- 2023-07-27
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Provider:
- Primary care provider (medical doctor/osteopathic physician, nurse practitioner, physician assistant [MD/DO, NP, PA]) assigned to a PACT from VA Puget Sound Health Care System or Edith Nourse Rogers Memorial Veterans Hospital (Bedford VA).
- Patient:
- Patient is a Veteran who is assigned a VA PCP and has received Rx for an inhaled corticosteroid within the past 180 days.
- Patient has an inpatient or outpatient diagnosis of COPD in the prior two years.
- Patient has undergone spirometry in the past 5 years that indicates either no airflow obstruction or mild to moderate airflow obstruction indicated by a forced expiratory volume 1 (FEV1)/[greater of forced vital capacity (FVC) or vital capacity (VC)] =< 0.7 \& FEV1% predicted >= 30%.
You may not qualify if…
- Patients:
- Very severe airflow obstruction (<30% FEV1 % predicted)
- Severe disease as indicated by 1 inpatient COPD exacerbation in the year prior
- Severe disease as indicated by 2 outpatient COPD exacerbations in the year prior
- International Classification of Diseases (ICD) 9 and/or 10 diagnosed or clinically indicated asthmatics
- Significant bronchodilator response on spirometry (>12% increase in FEV1 post bronchodilator; >375 mL post-bronchodilator improvement)
Where it is running
- VA Bedford HealthCare System, Bedford, MA — Bedford, Massachusetts, United States
- VA Puget Sound Health Care System Seattle Division, Seattle, WA — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.